Hans-christian Kornau

Berlin, BE, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

High-Affinity Human Germline and Mutated Autoantibodies Commonly Cross-React to Self-Antigens in 5 Subgroups of Autoimmune Encephalitis.

High-Affinity Human Germline and Mutated Autoantibodies Commonly Cross-React to Self-Antigens in 5 Subgroups of Autoimmune Encephalitis.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: June 17, 2026

The functional impact of LGI1 autoantibodies on human CA3 pyramidal neurons.

The functional impact of LGI1 autoantibodies on human CA3 pyramidal neurons.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: May 18, 2026

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Journal: Research square

Published: March 27, 2026

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Engineered Bi-Specific AChR CAAR T Cells for Selective Elimination of Myasthenia Gravis B Cells.

Journal: Research square

Published: March 27, 2026

Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models.

Bispecific chimeric autoantibody receptor T cells eliminate acetylcholine receptor-specific B cells in myasthenia gravis models.

Journal: Nature communications

Published: March 11, 2026

Specific viral antibodies associate with anti-NMDAR encephalitis after herpes simplex encephalitis.

Specific viral antibodies associate with anti-NMDAR encephalitis after herpes simplex encephalitis.

Journal: Brain, behavior, and immunity

Published: April 02, 2025

Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1-ADAM22/23 pathway.

Biallelic LGI1 and ADAM23 variants cause hippocampal epileptic encephalopathy via the LGI1-ADAM22/23 pathway.

Journal: Brain : a journal of neurology

Published: December 15, 2024

Patient-derived monoclonal LGI1 autoantibodies elicit seizures, behavioral changes and brain MRI abnormalities in rodent models.

Patient-derived monoclonal LGI1 autoantibodies elicit seizures, behavioral changes and brain MRI abnormalities in rodent models.

Journal: Brain, behavior, and immunity

Published: November 12, 2024

Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells.

Chimeric autoantibody receptor T cells deplete NMDA receptor-specific B cells.

Journal: Cell

Published: April 19, 2023

Brain blood vessel autoantibodies in patients with NMDA and GABAA receptor encephalitis: identification of unconventional Myosin-X as target antigen.

Brain blood vessel autoantibodies in patients with NMDA and GABAA receptor encephalitis: identification of unconventional Myosin-X as target antigen.

Journal: Frontiers in cellular neuroscience

Published: October 22, 2022

Oligodendrocyte-derived LGI3 and its receptor ADAM23 organize juxtaparanodal Kv1 channel clustering for short-term synaptic plasticity.

Oligodendrocyte-derived LGI3 and its receptor ADAM23 organize juxtaparanodal Kv1 channel clustering for short-term synaptic plasticity.

Journal: Cell reports

Published: September 09, 2022

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron.

Preclinical safety and efficacy of a therapeutic antibody that targets SARS-CoV-2 at the sotrovimab face but is escaped by Omicron.

Journal: iScience

Published: August 08, 2022

Showing 1-12 of 24

Last Updated: 09/26/2026